JP2022519301A5 - - Google Patents
Info
- Publication number
- JP2022519301A5 JP2022519301A5 JP2021545808A JP2021545808A JP2022519301A5 JP 2022519301 A5 JP2022519301 A5 JP 2022519301A5 JP 2021545808 A JP2021545808 A JP 2021545808A JP 2021545808 A JP2021545808 A JP 2021545808A JP 2022519301 A5 JP2022519301 A5 JP 2022519301A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962801717P | 2019-02-06 | 2019-02-06 | |
| US62/801,717 | 2019-02-06 | ||
| PCT/IB2020/050884 WO2020161623A1 (en) | 2019-02-06 | 2020-02-04 | N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519301A JP2022519301A (ja) | 2022-03-22 |
| JP2022519301A5 true JP2022519301A5 (https=) | 2023-02-13 |
| JPWO2020161623A5 JPWO2020161623A5 (https=) | 2023-02-13 |
Family
ID=69528901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545808A Withdrawn JP2022519301A (ja) | 2019-02-06 | 2020-02-04 | Ｎ－（ピリジン－２－イル）ピリジン－スルホンアミド誘導体及び疾患の処置におけるそれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220127247A1 (https=) |
| EP (1) | EP3921313A1 (https=) |
| JP (1) | JP2022519301A (https=) |
| CN (1) | CN113423702A (https=) |
| WO (1) | WO2020161623A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7214743B2 (ja) | 2018-02-15 | 2023-01-30 | バーテックス ファーマシューティカルズ インコーポレイテッド | 嚢胞性線維症膜コンダクタンス制御因子のモジュレーターとしての大環状分子、それらの医薬組成物、嚢胞性線維症の治療におけるそれらの使用、及びそれらの製造方法 |
| UY38630A (es) | 2019-04-03 | 2020-10-30 | Vertex Pharma | Agentes moduladores del regulador de la conductancia transmembrana de la fibrosis quística |
| WO2021030552A1 (en) | 2019-08-14 | 2021-02-18 | Vertex Pharmaceuticals Incorporated | Crystalline forms of cftr modulators |
| TWI867024B (zh) | 2019-08-14 | 2024-12-21 | 美商維泰克斯製藥公司 | 囊腫纖維化跨膜傳導調節蛋白之調節劑 |
| TWI899097B (zh) | 2019-08-14 | 2025-10-01 | 美商維泰克斯製藥公司 | 製備cftr調節劑之方法 |
| IL300413A (en) | 2020-08-13 | 2023-04-01 | Vertex Pharma | Crystal forms of CFTR modulators |
| KR20230118123A (ko) | 2020-12-10 | 2023-08-10 | 버텍스 파마슈티칼스 인코포레이티드 | 낭성 섬유증 치료 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0301654D0 (sv) * | 2003-06-05 | 2003-06-05 | Astrazeneca Ab | Novel compounds |
| US9745292B2 (en) * | 2014-03-13 | 2017-08-29 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods for increasing CFTR activity |
| US10047051B2 (en) * | 2015-06-02 | 2018-08-14 | Abbvie S.Á.R.L. | Substituted pyridines and method of use |
| TW201811766A (zh) * | 2016-08-29 | 2018-04-01 | 瑞士商諾華公司 | N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途 |
-
2020
- 2020-02-04 JP JP2021545808A patent/JP2022519301A/ja not_active Withdrawn
- 2020-02-04 WO PCT/IB2020/050884 patent/WO2020161623A1/en not_active Ceased
- 2020-02-04 CN CN202080011826.1A patent/CN113423702A/zh active Pending
- 2020-02-04 US US17/428,353 patent/US20220127247A1/en not_active Abandoned
- 2020-02-04 EP EP20704607.9A patent/EP3921313A1/en not_active Withdrawn